A Phase II Study of High Dose Epirubicin in Unresectable Non Small Cell Lung Cancer
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1992.82
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 1992
Authors
Publisher
Springer Science and Business Media LLC